All News #Library
Sciences
Soligenix receives Hong Kong patent for therapeutic use synthetic hypericin
02 Feb 2021 //
PHARMABIZ
Soligenix Announces Strategic Partnership with Daavlin for Supply of the SGX301
07 Jan 2021 //
PRNEWSWIRE

Market Place
Sourcing Support